Adiuvo Diagnostics develops a multispectral autofluorescence imaging device that utilizes machine learning algorithms for rapid, label-free disease detection, tailored for low-resource environments. This technology addresses the need for efficient early diagnosis of pathogens, skin conditions, and cancer, improving healthcare outcomes in underserved areas.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional diagnostic methods often require specialized equipment, trained personnel, and laboratory infrastructure, creating barriers to timely and accurate disease detection, especially in resource-limited settings. This can lead to delayed diagnoses and poorer health outcomes for underserved populations.
Solution
Adiuvo Diagnostics has developed a multispectral autofluorescence imaging device that uses machine learning algorithms to enable rapid, label-free disease detection. The device captures spectral images, which are then analyzed using proprietary algorithms to assist in the diagnosis of pathogens, skin conditions, and cancer. The technology is designed to be efficient and accessible, making it suitable for use in low-resource environments where traditional diagnostic tools may be unavailable or impractical.
Target Audience
The primary target audience includes healthcare providers and organizations operating in low-resource settings, as well as researchers and clinicians seeking rapid, label-free diagnostic tools.
Features
- Multispectral autofluorescence imaging for capturing detailed spectral data.
- Machine learning algorithms for automated analysis and disease detection.
- Label-free diagnostics, eliminating the need for specialized reagents.
- Applications ranging from pathogen detection to skin parameter evaluation and cancer diagnosis.
- Designed for use in low-resource settings, improving accessibility to diagnostic testing.